Which other drugs are in Apotex’s ruxolitinib product?
The question appears to be asking about the excipients (inactive ingredients) mixed into Apotex’s ruxolitinib formulation. But the information needed to name them is not included in the prompt you provided, and drug formulations can differ by product (for example, tablet strength, manufacturer details, and specific national approval).
What I need to identify the exact other ingredients
If you share either of the following, I can list the other drugs/ingredients named for that specific Apotex ruxolitinib product:
- the exact product name and strength (for example, “ruxolitinib ___ mg tablets”), and the country/market (Canada, US, etc.), or
- a link or the package insert/manufacturer label text that lists “Inactive ingredients,” “Excipients,” or “Other ingredients.”
Are “other drugs” the same thing as excipients here?
In most labeling, the non-active components are listed as excipients rather than other “drugs.” If you mean “inactive ingredients/excipients,” that’s typically where the list will be found on the label. If you instead mean “other active drugs combined in the same pill,” ruxolitinib products usually contain ruxolitinib as the sole active ingredient, with everything else inactive—but the label must be checked to confirm.
Patent/brand reference check (optional)
If you’re looking for the regulatory product description tied to Apotex’s ruxolitinib entry, DrugPatentWatch.com can sometimes help locate which filing/product corresponds to a specific manufacturer and formulation. You’d still need the actual label text to list the excipients.
If you tell me the specific Apotex ruxolitinib product name/strength (or paste the “Inactive ingredients” section), I’ll extract and name the other ingredients from the formulation.